Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
40.42B | 42.08B | 41.10B | 51.02B | 32.85B | 27.82B | Gross Profit |
4.43B | 4.37B | 4.79B | 4.86B | 3.96B | 3.85B | EBIT |
933.00M | 858.00M | 1.22B | 1.41B | 631.00M | 750.00M | EBITDA |
1.49B | 1.79B | 2.08B | 2.22B | 1.38B | 1.52B | Net Income Common Stockholders |
417.00M | 382.00M | 626.00M | 694.00M | 367.00M | 446.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.33B | 5.32B | 5.19B | 5.89B | 5.72B | 6.30B | Total Assets |
51.81B | 47.74B | 44.85B | 45.69B | 44.65B | 43.67B | Total Debt |
17.79B | 18.01B | 17.19B | 17.23B | 18.33B | 17.37B | Net Debt |
10.46B | 12.69B | 12.35B | 11.34B | 12.61B | 11.07B | Total Liabilities |
35.66B | 31.64B | 28.64B | 29.90B | 29.51B | 28.60B | Stockholders Equity |
15.71B | 15.66B | 15.78B | 15.31B | 14.68B | 14.58B |
Cash Flow | Free Cash Flow | ||||
0.00 | -97.00M | -185.00M | 1.68B | -1.87B | -1.20B | Operating Cash Flow |
0.00 | 906.00M | 503.00M | 2.33B | 398.00M | 711.00M | Investing Cash Flow |
0.00 | -1.03B | -741.00M | -613.00M | -1.60B | -1.52B | Financing Cash Flow |
0.00 | 235.00M | -472.00M | -1.56B | 622.00M | 627.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥63.24B | 7.40 | 3.07% | 41.28% | -11.01% | ||
74 Outperform | ¥59.19B | 10.49 | 3.44% | 4.32% | -6.85% | ||
73 Outperform | ¥7.15B | 5.43 | 5.10% | -0.11% | -19.84% | ||
72 Outperform | ¥5.34B | 13.99 | 5.68% | 2.36% | -38.98% | ||
68 Neutral | ¥48.04B | 7.97 | 3.32% | 5.73% | 27.30% | ||
66 Neutral | $4.46B | 12.11 | 5.38% | 5.02% | 4.17% | -11.82% | |
64 Neutral | ¥12.29B | 19.59 | 1.79% | 8.01% | 28.29% |